Open Access
Open access
The Lancet Regional Health - Americas, volume 33, pages 100726

The impact of COVID-19 on deaths from dementia and Alzheimer’s disease in Chile: an analysis of panel data for 16 regions, 2017–2022

Claudia Barría Sandoval 1
Guillermo Ferreira 2
Jean Paul Navarrete Campos 2, 3
Maryam Farhang 4, 5, 6
4
 
Facultad de Salud y Ciencias Sociales, Universidad de Las Américas, Santiago, Chile
5
 
Millennium Institute for Care Research (MICARE), Santiago, Chile
6
 
Millennium Institute for Research in Depression and Personality (MIDAP), Santiago, Chile
Publication typeJournal Article
Publication date2024-05-01
scimago Q1
SJR2.951
CiteScore8.0
Impact factor7
ISSN2667193X
Public Health, Environmental and Occupational Health
Health Policy
Internal Medicine
Abstract
BackgroundAlthough several studies have documented the detrimental impacts of global COVID-19 containment measures on individuals with Alzheimer's disease and dementia, a comprehensive analysis of mortality rates for these conditions within the Chilean population is notably lacking. This study aimed to analyze the impact of COVID-19 on mortality rates among individuals with dementia and Alzheimer's disease in Chile.MethodsA retrospective longitudinal cross-sectional study was conducted, considering mortality data for specific mental health conditions during the pre-pandemic and pandemic contexts of COVID-19 in Chile. Quantile regression techniques were employed to analyze the existence of differences between the two periods, while non-observable heterogeneity models for panel data methods were used to evaluate the effect of COVID-19 mortality on crude mortality rates.FindingsStatistically significant differences were observed in the number of deaths from dementia and Alzheimer's disease between the pre-pandemic and COVID-19 pandemic periods. Specifically, crude mortality rates decreased by 10% (−0.10 [95% CI: −0.16, −0.05]) during the pandemic period. Furthermore, the number of deaths from COVID-19 during the pandemic period has a very weak incidence of deaths from mental health conditions such as dementia and Alzheimer's. Specifically, a unit percentage increase in confirmed cases from COVID-19 would result in a 7% (−0.07 [95% CI: −0.13, −0.001]) decrease in the number of deaths from dementia and Alzheimer's. These findings are supported by the application of panel regression with one-way random effects models.InterpretationThe study findings indicate a reduction in mortality rates attributed to dementia and Alzheimer's disease during the COVID-19 pandemic in Chile. This decline could be attributed to the potential underreporting of mental illness as the cause of death during the pandemic period. Several studies have highlighted that approximately 30% of death certificates fail to document the presence of a dementia syndrome. Moreover, the cause of death recorded for individuals with mental health conditions may be influenced by the physician's familiarity with the patient or reflect the prevailing approach to managing end-stage dementia patients.FundingThis work received no funding.
Found 

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Share
Cite this
GOST | RIS | BibTex
Found error?